Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1977 Aug;32(4):424–428. doi: 10.1136/thx.32.4.424

Interaction between isoprenaline and aminophylline in asthma

I A Campbell 1,2,3,1, W G Middleton 1,2,3, G J R McHardy 1,2,3, Margaret V Shotter 1,2,3, Robin McKenzie 1,2,3, A B Kay 1,2,3,2
PMCID: PMC470643  PMID: 201045

Abstract

Campbell, I. A., Middleton, W. G., McHardy, G. J. R., Shotter, Margaret V., McKenzie, R., and Kay, A. B. (1977).Thorax, 32, 424-428. Interaction between isoprenaline and aminophylline in asthma. Using a factorially designed study, 38 patients with bronchial asthma received a single dose of either isoprenaline by inhalation (9), aminophylline intravenously (10), isoprenaline and aminophylline (11), or placebo (8). The maximum expiratory flow (V max), the maximum expiratory flow at 50% of vital capacity (V max50), and the concentrations of plasma cyclic AMP were measured at time intervals up to two hours. The combination of isoprenaline and aminophylline acted synergistically in terms of the percent increase in V max50. However, this was statistically significant only at 20 minutes. Plasma cyclic AMP concentration rose with a similar time course of response to the changes in small airways. The elevations in plasma cyclic AMP observed with the drug combination were higher than those for the individual drugs at 10, 20, 30, and 60 minutes but these differences were not statistically significant. These observations support the concept that changes in bronchial smooth muscle tone are mediated by concentrations of cyclic nucleotides and that combinations of isoprenaline and aminophylline, rather than the administration of each drug separately, may have therapeutic advantages in the treatment of bronchial asthma.

Full text

PDF
424

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUTCHER R. W., SUTHERLAND E. W. Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine. J Biol Chem. 1962 Apr;237:1244–1250. [PubMed] [Google Scholar]
  2. Ball J. H., Kaminsky N. I., Hardman J. G., Broadus A. E., Sutherland E. W., Liddle G. W. Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man. J Clin Invest. 1972 Aug;51(8):2124–2129. doi: 10.1172/JCI107019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Broadus A. E., Hardman J. G., Kaminsky N. I., Ball J. H., Sutherland E. W., Liddle G. W. Extracellular cyclic nucleotides. Ann N Y Acad Sci. 1971 Dec 30;185:50–66. doi: 10.1111/j.1749-6632.1971.tb45235.x. [DOI] [PubMed] [Google Scholar]
  4. Cohen B. M., Elizabeth N. J. Sympathomimetic xanthine broncholysis in obstructive ventilatory disorders. Int J Clin Pharmacol. 1974 Jan;9(1):6–15. [PubMed] [Google Scholar]
  5. Ellul-Micallef R., Fenech F. F. Effect of intravenous prednisolone in asthmatics with diminished adrenergic responsiveness. Lancet. 1975 Dec 27;2(7948):1269–1271. doi: 10.1016/s0140-6736(75)90608-x. [DOI] [PubMed] [Google Scholar]
  6. Gilman A. G. A protein binding assay for adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A. 1970 Sep;67(1):305–312. doi: 10.1073/pnas.67.1.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HUME K. M., RHYS JONES E. The response to bronchodilators in intrinsic asthma. Q J Med. 1961 Apr;30:189–199. [PubMed] [Google Scholar]
  8. Kaliner M. A., Orange R. P., Koopman W. J., Austen K. F., Laraia P. J. Cyclic adenosine 3',5'-monophosphate in human lung. Biochim Biophys Acta. 1971 Oct;252(1):160–164. doi: 10.1016/0304-4165(71)90104-8. [DOI] [PubMed] [Google Scholar]
  9. Karlberg B. E., Henriksson K. G., Andersson R. G. Cyclic adenosine 3',5'-monophosphate concentration in plasma, adipose tissue and skeletal muscle in normal subjects and in patients with hyper- and hypothyroidism. J Clin Endocrinol Metab. 1974 Jul;39(1):96–101. doi: 10.1210/jcem-39-1-96. [DOI] [PubMed] [Google Scholar]
  10. Lichtenstein L. M., Margolis S. Histamine release in vitro: inhibition by catecholamines and methylxanthines. Science. 1968 Aug 30;161(3844):902–903. doi: 10.1126/science.161.3844.902. [DOI] [PubMed] [Google Scholar]
  11. McFadden E. R., Jr, Linden D. A. A reduction in maximum mid-expiratory flow rate. A spirographic manifestation of small airway disease. Am J Med. 1972 Jun;52(6):725–737. doi: 10.1016/0002-9343(72)90078-2. [DOI] [PubMed] [Google Scholar]
  12. Palmer K. N., Gaddie J., Skinner C. Letter: Alpha-adrenoceptor-blocking drugs in asthma. Br Med J. 1974 Nov 16;4(5941):409–409. doi: 10.1136/bmj.4.5941.409-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Patel K. R., Kerr J. W. Letter: Alpha-receptor-blocking drugs in bronchial asthma. Lancet. 1975 Feb 8;1(7902):348–349. doi: 10.1016/s0140-6736(75)91271-4. [DOI] [PubMed] [Google Scholar]
  14. Pearson R. M., Bending M. R., Bulpitt C. J., George C. F., Hole D. R., Williams F. M., Breckenridge A. M. Trial of combination of guanethidine and oxprenolol in hypertension. Br Med J. 1976 Apr 17;1(6015):933–936. doi: 10.1136/bmj.1.6015.933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pihlajamäki K., Kanto J., Iisalo E. Human and animal studies on the interactions between glyphylline and isoprenaline. J Asthma Res. 1972 Jun;9(4):255–261. doi: 10.3109/02770907209105656. [DOI] [PubMed] [Google Scholar]
  16. RALL T. W., WEST T. C. The potentiation of cardiac inotropic responses to norepinephrine by theophylline. J Pharmacol Exp Ther. 1963 Mar;139:269–274. [PubMed] [Google Scholar]
  17. ROBINSON S., PEARCY M., BRUECKMAN F. R., NICHOLAS J. R., MILLER D. I. Effects of atropine on heart rate and oxygen intake in working man. J Appl Physiol. 1953 Mar;5(9):508–512. doi: 10.1152/jappl.1953.5.9.508. [DOI] [PubMed] [Google Scholar]
  18. Robinson B. F., Epstein S. E., Beiser G. D., Braunwald E. Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise. Circ Res. 1966 Aug;19(2):400–411. doi: 10.1161/01.res.19.2.400. [DOI] [PubMed] [Google Scholar]
  19. VELDSTRA H. Synergism and potentiation with special reference to the combination of structural analogues. Pharmacol Rev. 1956 Sep;8(3):339–387. [PubMed] [Google Scholar]
  20. Wehmann R. E., Blonde L., Steiner A. L. Sources of cyclic nucleotides in plasma. J Clin Invest. 1974 Jan;53(1):173–179. doi: 10.1172/JCI107535. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES